Stay updated on Nab-Paclitaxel & Pyrotinib in HER2+ Breast Cancer Adjuvant Clinical Trial

Sign up to get notified when there's something new on the Nab-Paclitaxel & Pyrotinib in HER2+ Breast Cancer Adjuvant Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nab-Paclitaxel & Pyrotinib in HER2+ Breast Cancer Adjuvant Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    A new revision entry v3.5.4 was added to the record history, replacing the previous v3.5.3 entry. This update reflects a revision history change rather than a modification to the study content.
    Difference
    0.1%
    Check dated 2026-05-16T10:34:53.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    41 days ago
    Change Detected
    Summary
    The page’s displayed site/browser revision has been updated from version v3.5.2 to v3.5.3, indicating a platform/UI maintenance update rather than a change to the trial record itself.
    Difference
    0.1%
    Check dated 2026-04-24T22:27:21.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2; Removed Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T14:12:22.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    New revision v3.5.0 has been added to the Record History. The revision v3.4.3 entry has been removed.
    Difference
    0.1%
    Check dated 2026-03-20T00:22:03.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    Added a new revision entry v3.4.3 and deleted revision v3.4.2 from the record history.
    Difference
    0.1%
    Check dated 2026-03-05T18:29:46.000Z thumbnail image
  9. Check
    113 days ago
    Change Detected
    Summary
    A new revision tag (v3.4.2) was added to the record history, replacing the previous v3.4.1, indicating a minor metadata update. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-12T03:59:11.000Z thumbnail image

Stay in the know with updates to Nab-Paclitaxel & Pyrotinib in HER2+ Breast Cancer Adjuvant Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nab-Paclitaxel & Pyrotinib in HER2+ Breast Cancer Adjuvant Clinical Trial page.